A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

NCT02517021 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Nausea and Vomiting

Interventions

DRUG: Pro-netupitant/Palonosetron
DRUG: Netupitant/Palonosetron
DRUG: Dexamethasone

Sponsor

Helsinn Healthcare SA

Collaborators

[object Object]